EPIX Pharmaceuticals, Inc. (EPIX) Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
10/16/2009 11:09:03 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces a Successful Auction Sale of Five Drug Program Intellectual Properties on September 30, 2009
10/1/2009 10:33:03 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
8/25/2009 11:20:34 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces August 25, 2009 for the Auction Sale of Equipment and September 30, 2009 for the Auction Sale of the Intellectual Property
8/4/2009 8:19:49 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Assigns all Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
7/22/2009 9:12:11 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Assigns All of Its Assets for the Benefit of Creditors
7/21/2009 10:03:36 AM
More...
|
Delisting of Securities of EPIX Pharmaceuticals, Inc. (EPIX) From The NASDAQ Stock Market
7/17/2009 8:50:14 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces Noteholders' Right to Require the Company to Repurchase $3.2 Million Outstanding Balance of 3% Convertible Senior Notes Due 2024
6/4/2009 9:47:00 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces Receipt of NASDAQ Panel Decision to Delist Common Stock
5/14/2009 9:10:43 AM
More...
|
EPIX Pharmaceuticals, Inc. (EPIX) Announces First Quarter 2009 Financial Results
5/12/2009 9:34:41 AM
More...
|
|